RAIN Rain Oncology Inc.
Rain Oncology Inc. (RAIN) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 19, 2026 , by Seidl Randy .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Seidl Randy 2 fills | Chief Executive Officer | Buy | 220,000 | $0.95 | $208.5K | 754,834 | |
| Seidl Randy | Chief Executive Officer | Buy | 4,000 | $2.58 | $10.3K | 644,834 | |
| Seidl Randy | Chief Executive Officer | Buy | 30,000 | $2.53 | $75.9K | 640,834 | |
| Seidl Randy | Chief Executive Officer | Buy | 8,514 | $1.73 | $14.7K | 610,834 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.